Last reviewed · How we verify
Peptostreptococcus Peritonitis
Approved treatments
- Metro I.V. In Plastic Container · Baxter
- Ceftriaxon · Centre Hospitalier Universitaire Vaudois
- Merrem · National Institutes of Health Clinical Center (CC)
- Merrem · Pfizer
Meropenem works by inhibiting bacterial cell wall synthesis, ultimately leading to bacterial cell death. - Epocelin
- Rocephin · Generic (originally Roche)
- Metronidazol · University of Oslo
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Peptostreptococcus Peritonitis patent landscape — cliff calendar, originator estates, attackable patents
- Peptostreptococcus Peritonitis treatment landscape brief
- Peptostreptococcus Peritonitis treatment updates RSS
Frequently asked questions about Peptostreptococcus Peritonitis
What drugs treat Peptostreptococcus Peritonitis?
Tracked treatments include Metro I.V. In Plastic Container, Ceftriaxon, Merrem, Epocelin, Rocephin, Metronidazol.
What is the treatment for Peptostreptococcus Peritonitis?
Standard treatment for Peptostreptococcus Peritonitis includes Metro I.V. In Plastic Container, Ceftriaxon, Merrem, Epocelin, Rocephin. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Peptostreptococcus Peritonitis patent cliff · Peptostreptococcus Peritonitis CI report
- Treatment: Metro I.V. In Plastic Container · Baxter
- Treatment: Ceftriaxon · Centre Hospitalier Universitaire Vaudois
- Treatment: Merrem · National Institutes of Health Clinical Center (CC)
- Treatment: Merrem · Pfizer
- Treatment: Epocelin
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing